News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
59,080 Results
Type
Article (3751)
Company Profile (13)
Press Release (55316)
Multimedia
Podcasts (5)
Webinars (4)
Section
Business (21922)
Career Advice (70)
Deals (3812)
Drug Delivery (11)
Drug Development (4428)
Employer Resources (13)
FDA (933)
Job Trends (1130)
News (30074)
Policy (1416)
Tag
2024 BioCapital Digital (1)
2024 Biotech Bay Standard (3)
2024 Biotech Beach Standard (2)
2024 Genetown Standard (1)
Academia (266)
Allergies (3)
Alliances (5311)
ALS (7)
Alzheimer's disease (123)
Antibody-drug conjugate (ADC) (7)
Approvals (931)
Artificial intelligence (44)
Autoimmune disease (4)
Automation (1)
Bankruptcy (33)
Best Places to Work (819)
BIOSECURE Act (2)
Biosimilars (7)
Biotechnology (13)
Bladder cancer (6)
Brain cancer (2)
Breast cancer (16)
Cancer (150)
Cardiovascular disease (12)
Career advice (63)
Career pathing (3)
CAR-T (14)
Cell therapy (35)
Clinical research (3419)
Collaboration (93)
Compensation (3)
Complete response letters (1)
COVID-19 (162)
CRISPR (4)
C-suite (41)
Cystic fibrosis (14)
Data (135)
Denatured (2)
Depression (4)
Diabetes (18)
Diagnostics (627)
Digital health (3)
Diversity (1)
Diversity, equity & inclusion (2)
Drug discovery (18)
Drug pricing (11)
Duchenne muscular dystrophy (3)
Earnings (4518)
Editorial (4)
Employer resources (11)
Events (5571)
Executive appointments (128)
FDA (1007)
Featured Employer (2)
Friedreich's ataxia (1)
Funding (365)
Gene editing (10)
Generative AI (4)
Gene therapy (29)
GLP-1 (68)
Government (143)
Guidances (4)
Healthcare (1329)
Huntington's disease (1)
IgA nephropathy (3)
Immunology and inflammation (17)
Indications (1)
Infectious disease (172)
Inflammatory bowel disease (14)
Inflation Reduction Act (4)
Influenza (2)
Intellectual property (11)
Interviews (5)
IPO (1775)
IRA (8)
Job creations (321)
Job search strategy (61)
Labor market (6)
Layoffs (37)
Leadership (1)
Legal (278)
Liver cancer (5)
Lung cancer (21)
Lymphoma (7)
Machine learning (1)
Management (5)
Manufacturing (30)
MASH (6)
Medical device (1297)
Medtech (1299)
Mergers & acquisitions (2102)
Metabolic disorders (65)
Multiple sclerosis (3)
NASH (1)
Neurodegenerative disease (16)
Neuropsychiatric disorders (1)
Neuroscience (163)
NextGen: Class of 2025 (985)
Non-profit (322)
Northern California (257)
Now hiring (1)
Obesity (40)
Opinion (48)
Ovarian cancer (3)
Pain (7)
Pancreatic cancer (1)
Parkinson's disease (10)
Partnered (5)
Patents (13)
Patient recruitment (10)
Peanut (3)
People (8875)
Pharmaceutical (4)
Phase I (1110)
Phase II (1551)
Phase III (1020)
Pipeline (74)
Policy (14)
Postmarket research (127)
Preclinical (612)
Press Release (7)
Prostate cancer (8)
Psychedelics (2)
Radiopharmaceuticals (27)
Rare diseases (40)
Real estate (586)
Recruiting (5)
Regulatory (1085)
Reports (3)
Research institute (198)
Resumes & cover letters (9)
RNA editing (2)
Schizophrenia (4)
Series A (101)
Series B (69)
Service/supplier (1)
Sickle cell disease (1)
Southern California (191)
Special edition (2)
Spinal muscular atrophy (1)
Sponsored (1)
Startups (2182)
Supply chain (4)
Tariffs (4)
The Weekly (3)
United States (1593)
Vaccines (26)
Venture capitalists (38)
Weight loss (20)
Women's health (2)
Date
Today (13)
Last 7 days (75)
Last 30 days (254)
Last 365 days (2856)
2025 (946)
2024 (3077)
2023 (3242)
2022 (5699)
2021 (5106)
2020 (4885)
2019 (4479)
2018 (3598)
2017 (3156)
2016 (2637)
2015 (3022)
2014 (2202)
2013 (1818)
2012 (1920)
2011 (2140)
2010 (2234)
Location
Africa (68)
Alabama (5)
Alaska (2)
Arizona (11)
Arkansas (5)
Asia (4111)
Australia (498)
California (573)
Canada (465)
China (50)
Colorado (14)
Connecticut (26)
Delaware (5)
Europe (8477)
Florida (31)
Georgia (15)
Idaho (5)
Illinois (44)
India (6)
Indiana (22)
Iowa (1)
Japan (22)
Kansas (7)
Kentucky (1)
Louisiana (5)
Maine (6)
Maryland (44)
Massachusetts (311)
Michigan (8)
Minnesota (16)
Missouri (10)
Nevada (2)
New Hampshire (5)
New Jersey (84)
New Mexico (4)
New York (105)
North Carolina (63)
Northern California (257)
Ohio (25)
Oklahoma (3)
Oregon (2)
Pennsylvania (56)
Puerto Rico (3)
Rhode Island (1)
South America (104)
South Carolina (2)
Southern California (191)
Tennessee (7)
Texas (64)
Utah (14)
Virginia (10)
Washington D.C. (2)
Washington State (37)
Wisconsin (6)
59,080 Results for "atlas venture".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
GLP-1
BioSpace
Presents the World Atlas of GLP-1s
Eli Lilly and Novo Nordisk are in a global battle for dominance in the weight loss space.
BioSpace
takes a look at the territory covered and what’s to come.
March 26, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
Children’s Hospital of Philadelphia Researchers Develop Cell Atlas to Uncover Significant Shifts in the Neuroblastoma Tumor Microenvironment
April 14, 2025
·
5 min read
Press Releases
Yemaachi Biotechnology Launches The African Cancer Atlas, in Partnership with Roche
February 18, 2025
·
4 min read
Business
Singleron Biotechnologies partners with the Human Cell Atlas (HCA) to enhance access to single cell analysis globally
Singleron Biotechnologies announced a partnership with the Human Cell Atlas (HCA) to help accelerate the adoption of single cell sequencing globally.
June 18, 2024
·
3 min read
Weight loss
Kailera Launches With $400M to Advance China-Developed Obesity Assets
Venture Capital firms Atlas Venture, Bain Capital Life Sciences and RTW Investments have led a $400 million Series A for Kailera Therapeutics, the latest obesity biotech to hit the scene.
October 1, 2024
·
1 min read
·
Annalee Armstrong
Press Releases
Vevo Therapeutics Partners with the Parse Biosciences GigaLab to Generate 100M Cell Atlas for AI Powered Drug Discovery
December 5, 2024
·
3 min read
Pharm Country
Biomolecular Atlas for Bone Marrow to Offer Unprecedented Window into Blood Production
Researchers at Children’s Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania revealed a powerful new bone marrow atlas that will offer the public a first-of-its-kind visual passport into the spectrum of healthy and diseased blood production.
May 6, 2024
·
5 min read
Press Releases
SNBL and Tasso, Inc. to Establish Joint Venture in Japan
March 28, 2025
·
2 min read
Business
AbCellera and Atlas Venture Collaborate to Empower the Development of Impactful Medicines for Patients
AbCellera (Nasdaq: ABCL) and Atlas Venture announced a multi-target partnership to discover therapeutic antibodies for up to three drug targets that can be developed and commercialized by a stealth-stage Atlas-backed company.
August 3, 2022
·
4 min read
Press Releases
Sirona Biochem Secures Strategic Investment Agreements and New Joint Venture with Promura GmbH
April 22, 2025
·
6 min read
1 of 5,908
Next
